Antiplatelet therapy in critical limb ischemia: update on clopidogrel and cilostazol

S Spiliopoulos1

  • 1Department of Interventional Radiology Patras University Hospital, Patras, Greece - stavspiliop@upatras.gr.

Insights

Antiplatelet therapy, including clopidogrel and cilostazol, is crucial for critical limb ischemia (CLI) patients. These treatments help prevent ischemic events and maintain blood vessel patency after revascularization procedures.

Area of Science:

  • Vascular Medicine
  • Pharmacology
  • Cardiovascular Research

Background:

  • Critical limb ischemia (CLI) necessitates antiplatelet therapy for preventing ischemic events.
  • Antiplatelet agents are vital for maintaining patency after revascularization in CLI patients.

Purpose of the Study:

  • To review current evidence on antiplatelet therapy in critical limb ischemia.
  • To focus on the roles of clopidogrel and cilostazol in managing CLI.

Main Methods:

  • Review of recent scientific literature and clinical guidelines.
  • Analysis of studies evaluating clopidogrel and cilostazol in CLI patients.

Main Results:

  • Clopidogrel monotherapy or dual therapy is recommended for CLI.
  • Cilostazol reduces restenosis and reinterventions after peripheral angioplasty/stenting.
  • Cilostazol enhances platelet inhibition in CLI patients.

Conclusions:

  • Antiplatelet therapy is a cornerstone in managing critical limb ischemia.
  • Clopidogrel and cilostazol demonstrate significant benefits in CLI treatment and prevention of thrombo-occlusive events.

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
653
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.6K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
443
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
658